CytoMed Therapeutics Ltd. (GDTC) Social Stream
CYTOMED THERAPEUTICS LTD (GDTC) Price Targets From Analysts
Use the tables below to see what analysts covering CYTOMED THERAPEUTICS LTD think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-07-21 | 1 | $5 | $5 | $5 | $4.54 | 10.13% |
| NA | 1 | $NA | $NA | $NA | $4.54 | NA% |
Price Target Last Issued NA NA, NA
GDTC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GDTC as an investment opportunity.
- CYTOMED THERAPEUTICS LTD's number of analysts covering the stock is greater than practically none of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, CYTOMED THERAPEUTICS LTD's variance in analysts' estimates is lower than just about 100% of them.
- In the context of Healthcare stocks, CYTOMED THERAPEUTICS LTD's average analyst price target is greater than 6.54% of them.
- To contextualize these metrics, consider that out of stocks in the nano market cap category, CYTOMED THERAPEUTICS LTD's upside potential (average analyst target price relative to current price) is greater than 13.47% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CYTOMED THERAPEUTICS LTD are CVKD, DRMA, and UNCY.
View All Top Stocks by Price Target
What is the outlook for GDTC? Use POWR Ratings for clearer insight into price direction.